SureTrader
Home > Boards > US Listed > Biotechs > Mast Therapeutics, Inc. (MSTX)

ANX i like this!! anyone see that gap

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
semipro11 Member Profile
 
Followed By 307
Posts 25,529
Boards Moderated 2
Alias Born 04/04/08
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/10/2016 9:02:44 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/9/2016 4:10:31 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/9/2016 9:01:26 AM
Mast Therapeutics Reports Second Quarter 2016 Financial Results "PR Newswire (US)" - 8/9/2016 8:00:00 AM
Mast Therapeutics Awarded Small Business Innovation Research Grant From The National Institutes Of Health "PR Newswire (US)" - 8/8/2016 8:00:00 AM
Mast Therapeutics Announces Issuance Of Composition Of Matter Patent Covering Vepoloxamer "PR Newswire (US)" - 8/3/2016 8:00:00 AM
Mast Therapeutics To Present At 36th Annual Canaccord Genuity Growth Conference On August 10 "PR Newswire (US)" - 8/2/2016 8:00:00 AM
Mast Therapeutics Announces Initiation Of Phase 2 Study Of AIR001 Conducted By The Heart Failure Clinical Research Network "PR Newswire (US)" - 8/1/2016 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/25/2016 5:03:24 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/17/2016 5:23:39 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/17/2016 5:21:57 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/17/2016 5:21:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 6/17/2016 5:17:42 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/17/2016 4:18:04 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/8/2016 4:16:48 PM
Mast Therapeutics Receives Notice Of Allowance Of Composition Of Matter Patent Application Covering Vepoloxamer "PR Newswire (US)" - 6/8/2016 4:05:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/6/2016 4:33:05 PM
Results of Vepoloxamer Nonclinical Studies in Advanced Heart Failure Presented at European Society of Cardiology 3rd World Co... "PR Newswire (US)" - 5/23/2016 8:00:00 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 5/17/2016 6:01:31 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 5/17/2016 6:00:53 AM
Positive Interim Results From Second Phase 2a Study Of AIR001 In Patients With Heart Failure With Preserved Ejection Fraction... "PR Newswire (US)" - 5/16/2016 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 5/16/2016 7:42:09 AM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 5/13/2016 5:34:31 PM
Post-effective Amendment to Registration Statement (pos Am) "Edgar (US Regulatory)" - 5/6/2016 4:36:33 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/6/2016 9:05:31 AM
semipro11   Wednesday, 03/21/12 11:27:13 AM
Re: Tommy post# 9617
Post # of 14198 
ANX i like this!! anyone see that gap to the 90's weeeeeeeeee

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist